An Improved (211)At-Labeled Agent for PSMA-Targeted alpha-Therapy. Mease RC, Kang CM, Kumar V, Banerjee SR, et al. J Nucl Med 2022;63:259-267.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mease RC, Kang CM, Kumar V, Banerjee SR, et al. An Improved (211)At-Labeled Agent for PSMA-Targeted alpha-Therapy. J Nucl Med 2022;63:259-267.
PMID: 34088772